methoxyhydroxyphenylglycol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, TG; Cohen, RM; Doudet, DJ; McLellan, CA | 1 |
| Goldstein, DS; Johannessen, JN; Markey, SP; Oliver, J | 1 |
| Audsley, AR; Sirinathsinghji, DJ; Whittington, PE | 1 |
| Burns, RS; Ebert, MH; Kopin, IJ; LeWitt, PA; Pakkenberg, H | 1 |
| Bankiewicz, K; Harvey-White, J; Kopin, IJ | 1 |
| Bey, P; McDonald, IA; Palfreyman, MG; Schechter, PJ; Sjoerdsma, A | 1 |
| Bankiewicz, KS; Harvey-White, J; Kopin, IJ | 1 |
| Deutch, AY; Elsworth, JD; Redmond, DE; Roth, RH; Sladek, JR | 1 |
| Arnold, LA; Blanchet, PJ; Chase, TN; Hyland, K; Konitsiotis, S; Pettigrew, KD | 1 |
| Imanishi, M; Kaneda, K; Kita, H; Nambu, A; Shigemoto, R; Tachibana, Y; Takada, M | 1 |
10 other study(ies) available for methoxyhydroxyphenylglycol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Positron emission tomography with 18F-dopa: interpretation and biological correlates in nonhuman primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbidopa; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Receptors, Dopamine; Tomography, Emission-Computed | 1992 |
Prolonged changes in plasma concentrations of catecholamine metabolites following a single infusion of an MPTP analog.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adrenal Glands; Animals; Catecholamines; Dogs; Female; Injections, Intravenous; Male; Methoxyhydroxyphenylglycol; Normetanephrine; Sympathetic Nervous System; Time Factors | 1990 |
Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Caudate Nucleus; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Substantia Nigra | 1986 |
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adult; Corpus Striatum; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Substance-Related Disorders; Substantia Nigra; Syndrome | 1985 |
Effect of MPTP-induced parkinsonism in monkeys on the urinary excretion of HVA and MHPG during debrisoquin administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Creatinine; Debrisoquin; Female; Glycols; Homovanillic Acid; Isoquinolines; Macaca mulatta; Methoxyhydroxyphenylglycol; Parkinson Disease, Secondary; Pyridines; Regression Analysis | 1988 |
Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Allyl Compounds; Allylamine; Amines; Animals; Blood Platelets; Blood Pressure; Brain; Butylamines; Carbidopa; Dogs; Female; Heart Rate; Humans; In Vitro Techniques; Isoenzymes; Male; Methoxyhydroxyphenylglycol; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Tyramine | 1988 |
Assessment of brain dopamine metabolism from plasma HVA and MHPG during debrisoquin treatment: validation in monkeys treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Debrisoquin; Designer Drugs; Dopamine; Female; Glycols; Homovanillic Acid; Isoquinolines; Kinetics; Macaca mulatta; Methoxyhydroxyphenylglycol; Pyridines | 1988 |
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Chlorocebus aethiops; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Pyridines; Tegmentum Mesencephali | 1987 |
Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Biopterins; Disease Models, Animal; Female; Free Radical Scavengers; Homovanillic Acid; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Motor Activity; Parkinson Disease, Secondary; Pilot Projects; Piperazines | 1998 |
Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Behavior, Animal; Benzoates; Cell Count; Disease Models, Animal; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Glycine; Immunohistochemistry; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Parkinsonian Disorders; Receptors, Metabotropic Glutamate; Severity of Illness Index; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |